Chembio Diagnostics
CEMI
#10214
Rank
$16.71 M
Marketcap
$0.46
Share price
0.22%
Change (1 day)
-56.25%
Change (1 year)

Revenue for Chembio Diagnostics (CEMI)

Revenue in 2022 (TTM): $48.33 Million USD

According to Chembio Diagnostics's latest financial reports the company's current revenue (TTM ) is $48.33 Million USD. In 2021 the company made a revenue of $36.92 Million USD an increase over the revenue in the year 2020 that were of $30.45 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Chembio Diagnostics from 2005 to 2022

Annual revenue

Year Revenue Change
2022 (TTM) $48.33 M30.91%
2021 $36.92 M21.26%
2020 $30.45 M-11.64%
2019 $34.46 M3.16%
2018 $33.4 M39.12%
2017 $24.01 M34.4%
2016 $17.86 M-26.33%
2015 $24.25 M-12.26%
2014 $27.64 M-6.44%
2013 $29.54 M15.38%
2012 $25.61 M32.09%
2011 $19.38 M16.06%
2010 $16.7 M20.75%
2009 $13.83 M25.2%
2008 $11.04 M19.7%
2007 $9.23 M41.96%
2006 $6.5 M65.01%
2005 $3.94 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
QuidelOrtho
QDEL
$2.71 B 5,515.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
$2.55 B 5,190.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Trinity Biotech
TRIB
$61.55 M 27.34%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
OraSure Technologies
OSUR
$0.12 B 160.04%๐Ÿ‡บ๐Ÿ‡ธ USA